Your Article Summary
MediGene receives Positive Assessment on Market Authorisation for Veregen in First European Countries
MediGene, 07/13/09
MediGene AG announces that its Marketing Authorisation Application for the medicinal product Veregen for the treatment of genital warts has been assessed positively by the national regulatory authorities of Germany, Austria, and Spain. This binding decision guarantees that national Marketing Authorisations in these countries will be formally granted by the authorities within the next few months. The Marketing Authorisation of Veregen in Germany, the Reference Member State in this Decentralized Procedure, shall provide the basis for additional Marketing Authorisations in other European countries via the Mutual Recognition Procedure.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09
Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Article Search
Sponsor


See Latest Articles


